New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 9, 2012
10:29 EDTAIG, HSY, VECO, UA, STJ, SMG, MGLN, IQNT, FOSL, EZPW, DOW, DMD, CPE, AFFX, PRTSOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: AIG (AIG) upgraded to Buy from Neutral at Goldman... Affymetrix (AFFX) upgraded to Equal Weight from Underweight at Morgan Stanley... Callon Petroleum (CPE) upgraded to Outperform from Neutral at RW Baird... Demand Media (DMD) upgraded to Buy from Neutral at Citigroup... Dow Chemical (DOW) upgraded to Overweight from Equal Weight at Morgan Stanley... EZCORP (EZPW) upgraded to Neutral from Underperform at Sterne Agee... Fossil (FOSL) upgraded to Buy from Hold at Benchmark Co... Inteliquent (IQNT) upgraded to Outperform from Neutral at RW Baird... Magellan Health (MGLN) upgraded to Buy from Neutral at BofA/Merrill... Scotts Miracle-Gro (SMG) upgraded to Market Perform from Underperform at BMO Capital... St. Jude Medical (STJ) upgraded to Overweight from Equal Weight at Morgan Stanley... Under Armour (UA) upgraded to Buy from Neutral at UBS... Veeco (VECO) upgraded to Overweight from Neutral at Piper Jaffray... Hershey (HSY) upgraded to Buy from Hold at Argus... U.S. Auto Parts (PRTS) upgraded to Buy from Neutral at Roth Capital.
News For AIG;AFFX;CPE;DMD;DOW;EZPW;FOSL;IQNT;MGLN;SMG;STJ;UA;VECO;HSY;PRTS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
October 16, 2014
09:08 EDTSTJSt. Jude Medical well-positioned heading into 2015, says Wedbush
Subscribe for More Information
08:53 EDTSTJSt. Jude Medical weakness a buying opportunity, says CRT Capital
CRT Capital would use St. Jude Medical weakness as a buying opportunity based on accelerating EPS growth and expects CardioMEMS to be a $1B revenue opportunity over the next few years. Shares are Buy rated with a $80 price target.
07:45 EDTSTJSt. Jude Medical price target lowered to $66 from $75 at Stifel
Subscribe for More Information
06:32 EDTAFFXAffymetrix and Ariosa Diagnostics sign multi-year prenatal test supply agreement
Subscribe for More Information
October 15, 2014
12:41 EDTDOWDow Chemical receives EPA registratoin for commercialization of Enlist
Dow Chemical announced it has received registration from the Environmental Protection Agency for its Enlist Duo herbicide for use with Enlist corn and soybeans. The Company expects sales of the Enlist Weed Control System to deliver significant value over the near and long term, and intends to release its market intentions in the coming weeks.
11:40 EDTCPECallon Petroleum weakness a buying opportunity, says Sterne Agee
Subscribe for More Information
09:38 EDTDOWActive equity options trading on open
Subscribe for More Information
08:37 EDTSTJSt. Jude Medical expects AF products revenue to accelerate in FY15
As the company look to FY15, aims to continue to accelerate its sales growth rate. Expects the acceleration to come from its men's heart failure monitor system and chronic pain business. Expects to grow sales faster in FY15 compared to FY14.
08:32 EDTSTJSt. Jude Medical sees YOY currency impact on sales $50M-$60M for Q4
Subscribe for More Information
07:34 EDTSTJSt. Jude Medical reports Q3 total CRM sales $688M
Subscribe for More Information
07:34 EDTSTJSt. Jude Medical narrows FY14 adjusted EPS view to $3.97-$3.99 from $3.96-$4.01
Subscribe for More Information
07:32 EDTDOWUBM Canon to hold a conference
PLASTEC Midwest Conference is being held in Chicago on October 15-16.
07:32 EDTSTJSt. Jude Medical sees Q4 adjusted EPS $1.02-$1.04, consensus $1.04
Subscribe for More Information
07:32 EDTSTJSt. Jude Medical Sees FY14 adjusted EPS $3.97-$3.99, consensus $3.98
Sees FY14 revenue $5.586B-$5.648B, consensus $5.69B.
07:31 EDTSTJSt. Jude Medical reports Q3 adjusted EPS 97c, consensus 96c
Reports Q3 revenue $1.37B, consensus $1.38B.
October 14, 2014
15:29 EDTSTJNotable companies reporting before tomorrow's open
Subscribe for More Information
11:21 EDTFOSLFossil initiated with a Buy at Standpoint Research
Target $124.
October 13, 2014
12:01 EDTHSYOptions with decreasing implied volatility
Options with decreasing implied volatility: EXAS INFY YUM FDO HSY
07:25 EDTSTJEuropean Association of Cardiothoracic Surgery to hold annual meeting
28th EACTS Annual Meeting is being held in Milan, Italy on October 11-15.
07:15 EDTDOWNational Association of Corporate Directors to hold a conference
Subscribe for More Information
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use